ResMed Debt to Equity Ratio 2010-2025 | RMD
Current and historical debt to equity ratio values for ResMed (RMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ResMed debt/equity for the three months ending March 31, 2025 was 0.12.
| ResMed Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $2.02B | $5.55B | 0.36 |
| 2024-12-31 | $1.89B | $5.25B | 0.36 |
| 2024-09-30 | $2.03B | $5.20B | 0.39 |
| 2024-06-30 | $2.01B | $4.86B | 0.41 |
| 2024-03-31 | $2.19B | $4.63B | 0.47 |
| 2023-12-31 | $2.42B | $4.48B | 0.54 |
| 2023-09-30 | $2.49B | $4.25B | 0.59 |
| 2023-06-30 | $2.62B | $4.13B | 0.64 |
| 2023-03-31 | $2.78B | $3.93B | 0.71 |
| 2022-12-31 | $2.94B | $3.74B | 0.79 |
| 2022-09-30 | $1.75B | $3.43B | 0.51 |
| 2022-06-30 | $1.74B | $3.36B | 0.52 |
| 2022-03-31 | $1.63B | $3.28B | 0.50 |
| 2021-12-31 | $1.59B | $3.15B | 0.51 |
| 2021-09-30 | $1.70B | $3.03B | 0.56 |
| 2021-06-30 | $1.84B | $2.89B | 0.64 |
| 2021-03-31 | $1.88B | $2.71B | 0.69 |
| 2020-12-31 | $1.71B | $2.87B | 0.60 |
| 2020-09-30 | $1.94B | $2.68B | 0.73 |
| 2020-06-30 | $2.09B | $2.50B | 0.84 |
| 2020-03-31 | $2.25B | $2.26B | 1.00 |
| 2019-12-31 | $2.10B | $2.26B | 0.93 |
| 2019-09-30 | $2.04B | $2.12B | 0.96 |
| 2019-06-30 | $2.04B | $2.07B | 0.98 |
| 2019-03-31 | $2.08B | $2.02B | 1.03 |
| 2018-12-31 | $1.90B | $1.96B | 0.97 |
| 2018-09-30 | $1.17B | $1.90B | 0.61 |
| 2018-06-30 | $1.01B | $2.06B | 0.49 |
| 2018-03-31 | $1.47B | $2.07B | 0.71 |
| 2017-12-31 | $1.54B | $2.02B | 0.77 |
| 2017-09-30 | $1.44B | $2.05B | 0.70 |
| 2017-06-30 | $1.51B | $1.96B | 0.77 |
| 2017-03-31 | $1.57B | $1.86B | 0.85 |
| 2016-12-31 | $1.61B | $1.71B | 0.94 |
| 2016-09-30 | $1.55B | $1.77B | 0.87 |
| 2016-06-30 | $1.56B | $1.70B | 0.92 |
| 2016-03-31 | $0.77B | $1.67B | 0.46 |
| 2015-12-31 | $0.72B | $1.52B | 0.47 |
| 2015-09-30 | $0.79B | $1.46B | 0.54 |
| 2015-06-30 | $0.59B | $1.59B | 0.38 |
| 2015-03-31 | $0.74B | $1.54B | 0.48 |
| 2014-12-31 | $0.74B | $1.59B | 0.47 |
| 2014-09-30 | $0.66B | $1.65B | 0.40 |
| 2014-06-30 | $0.60B | $1.76B | 0.34 |
| 2014-03-31 | $0.67B | $1.69B | 0.40 |
| 2013-12-31 | $0.71B | $1.64B | 0.43 |
| 2013-09-30 | $0.64B | $1.69B | 0.38 |
| 2013-06-30 | $0.60B | $1.61B | 0.37 |
| 2013-03-31 | $0.61B | $1.77B | 0.34 |
| 2012-12-31 | $0.58B | $1.75B | 0.33 |
| 2012-09-30 | $0.55B | $1.70B | 0.32 |
| 2012-06-30 | $0.53B | $1.61B | 0.33 |
| 2012-03-31 | $0.52B | $1.61B | 0.32 |
| 2011-12-31 | $0.48B | $1.56B | 0.31 |
| 2011-09-30 | $0.39B | $1.55B | 0.25 |
| 2011-06-30 | $0.34B | $1.73B | 0.20 |
| 2011-03-31 | $0.30B | $1.66B | 0.18 |
| 2010-12-31 | $0.27B | $1.61B | 0.17 |
| 2010-09-30 | $0.32B | $1.48B | 0.21 |
| 2010-06-30 | $0.34B | $1.29B | 0.26 |
| 2010-03-31 | $0.38B | $1.33B | 0.29 |
| 2009-12-31 | $0.36B | $1.26B | 0.29 |
| 2009-09-30 | $0.42B | $1.20B | 0.35 |
| 2009-06-30 | $0.39B | $1.12B | 0.35 |
| 2009-03-31 | $0.35B | $0.97B | 0.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.677B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.97 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |